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ABSTRACT 
The study aimed to gather evidence on the potential of golden berry (GB) juice  in improving blood 
glucose level, insulin level, and insulin resistance in type-2 diabetes mellitus (T2DM) in comparison to 
quercetin supplement in animal model. This study used true experimental pre-post-test study with control 
group design. Twenty five Wistar male rats were divided into five groups: healthy group (K-), T2DM 
positive control group (K+), T2DM group with 1 ml/200 g BW/day of GB juice (X1), T2DM group with 
5 ml/200 g BW/day of GB juice (X2), and T2DM group with 6 mg/200 g BW/day of quercetin (X3). 
The T2DM rasts were obtained from healthy rats induced by high-fat feed and Streptozotocin (STZ). 
The result showed that various dosages of GB juice (X1 and X2) were able to lower blood glucose level 
(-79.15; -110.44; -108.20) and HOMA-IR (-2.40; -2.92; -3.02). In addition, it was also able to increase 
insulin level (0.26; 1.99; 1.42) compared to (K+) group (p<0.05). In conclusion, GB juice was able to 
lower blood glucose level, insulin resistance, and increase insulin level in T2DM rats. The GB juice 
dosage of 1 ml/200 g BW/day and 5 ml/200 g BW/day were better in lowering the blood glucose level 
and improving insulin resistance compared to quercetin supplement.
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INTRODUCTION
Type-2 diabetes mellitus (T2DM) is a 
metabolic disorder marked by elevated blood 
sugar levels (hyperglycemia) due to decrease in 
pancreatic β-cell function or insulin resistance 
(Kahn et al. 2014). Type-2 diabetes mellitus, 
is a global pandemic. International Diabetes 
Federation (IDF) stated that in 2017, globally 
there was 425 million cases of T2DM and has 
been expected to reach 629 million cases in 2045. 
In Indonesia alone, the number of T2DM was 10 
million cases in 2015 (International Diabetes 
Federation 2017).
One of the underlying pathophysiology of 
T2DM is insulin resistance (Kahn et al. 2014), it 
is a complex metabolic disorder where the tissue 
capabilities to use insulin is reduced. Continous 
high intake of calories and accumulation of 
free fatty acids in some tissues can lead to 
insulin resistance, which perturb the utilization 
of glucose in the tissues (liver, muscle, and fat 
tissue). The insulin resistance causes reduction 
of insulin interaction with tissues and further 
disrupts the metabolic pathways of glucose, fat, 
and protein (Sah et al. 2016).
The hyperglycemia in type-2 diabetes 
mellitus increases the formation of advanced 
glycation end products (AGEs) and glucose 
oxidation which produce reactive oxygen species 
(ROS). The presence of ROS further plays a role 
in β-cell damage and reduces insulin sensitivity 
(Qatanani & Lazar 2007). The imbalance of 
free radicals and antioxidants in the body causes 
oxidative stress in T2DM (Chikezie et al. 
2015). Many studies have found that flavonoid 
content in food has a major role as antioxidant to 
improve T2DM (Anhe et al. 2013). The golden 
berry (Physalis peruviana) is one of such food 
that is also commonly utilized in Indonesia. The 
phenolic content in golden berry was 50–250 
mg/100 g of fruit and its antioxidant activity was 
210.82 μmoltrolox/100 g of fruit (Puente et al. 
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2011). Research also shown that golden berry 
has a role as anti-inflammatory, antioxidant, and 
anti-diabetic (Sathyadevi et al. 2014; Puente et al. 
2011). The main phenolic compounds in GB fruit 
are quercetin, myrecetin, and kaempferol (Puente 
et al. 2011).
Fruit juice is considered as functional 
food because it still contain the micronutrients or 
active substances from fresh fruits that provides 
physiological advantages (Ramadan & Moersel 
2006). Hassan & Ghoneim (2013) stated that 
the administration of GB juice with a 1 ml/200 
g BW/day dose in diabetic rats, could lower 
blood sugar significantly compared to untreated 
diabetic group. Quercetin content on golden berry 
extract in this study was able to improve pancreas 
β-cells function as an antioxidant agent.  In recent 
years, quercetin was not only available in food 
form but also in supplementation and generally 
introduced as therapy for bacterial infections, 
gout, hypertension, diabetes mellitus, asthma, and 
many more (Larson et al. 2012). Despite the ease 
of use of supplement, some patient prefer natural 
fresh remedies such as the golden berry fruit juice 
for long term use. Therefore, this study aimed 
to find evidences on the potential of the golden 
berry juice compared to quercetin supplement in 
improving blood glucose level, insulin level, and 
insulin resistance in type-2 diabetes mellitus rats. 
The results is expected to contribute to further 
study for Golden Berry functional food product 
development and efficacy testing in human 
subject.
METHODS
Design, location, and time
The study used true experimental study 
with completely randomized design pre-post-
test with control group design. This study was 
conducted at the Integrated Laboratory of 
Diponegoro University, Semarang for testing the 
content of quercetin in golden berry juice. Animal 
care and testing were conducted at Center for 
Food and Nutrition Research Laboratory, Gadjah 
Mada University, Yogyakarta from December 
2017 to February 2018.
Sampling
Determination of sample size in this study 
was based on World Health Organization (WHO 
2000) minimum sample for animal assay, which 
is 5 rats for each treatment group (WHO 2000). 
Twenty five male Wistar aged 8–12 weeks 
with 150–200 g of body weight were obtained 
from Center for Food and Nutrition Research 
Laboratory, Gadjah Mada University, Yogyakarta. 
GB fruits were obtained from the garden in 
Ciwidey, Bandung regency. Quercetin was 
obtained from Sigma Aldirch (Q4951, St.Louis, 
USA), Streptozotocin (STZ) was obtained from 
Nacalai Tesque Japan and Niconitamide (NA) 
was obtained from Nacalai Tesque, Japan. This 
study also used blood glucose check reagent 
(Dyasis) and insulin ELISA kit (Fine Test). 
The standard rat feed was consisted of 
Confeed AD II (composition: 12% water, 15% 
crude protein, 3–7% crude lipid, 6% crude 
fiber, 7% ash, 0.9–1.1% calcium, and 0.6–0.9% 
phosphorus) and the high-fat feed (composition: 
80% standard feed, 20% lard, and 1% extra 
cholesterol) were obtained from Center for Food 
and Nutrition Research Laboratory, Gadjah Mada 
University, Yogyakarta. Tools for animal care 
like cages, feeding plate, drinking bottle, digital 
scales, and blood sampling tools used micro 
hematocrit and syringe probe. 
GB juices were made using basins, 
blender, cheese cloth, spoon, and measuring cup. 
Blood analysis used a blood glucose check and 
insulin ELISA kit. Tools and materials used for 
testing the content of quercetin in GB juice were 
70% methanol, distilled water, Erlenmeyer tubes, 
beaker glasses, pipettes, ultrasonic (Branson), 
Whatman paper, micropipette 1,000 µL and 10-
100 µL, test tubes, and High Performance Liquid 
Chromatography (HPLC) (Shimadzu, Japan).
Procedures
Testing for Quercetin content in golden 
berry juice. Five ml of the sample juice were 
mixed with 25 ml of 70% methanol and 
extracted using the ultrasonic at 300C for 20 
minutes. Extracted sample was stored in freezing 
temperature for 24 hours and then filtered 
through a 0.45 µm filter. A 20 ml of sample was 
induced to HPLC instrument. The HPLC analysis 
was performed using a Shimadzu-LC system 
equipped with a UV-Vis detector (SPD-20AV), 
a column Purospher® STAR C18 (250 mm x 
4.0 mm, 5 µm), a flow rate of 1.1 ml/minutes, a 
column temperature of 300C, a mobile phase of 
Methanol : Acetonitrile : Water (60:20:20) % v/v 
and a detection wavelenght of 254 nm.
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Conditioning of type-2 diabetes mellitus.
Twenty-five Wistar male rats were acclimatized 
to individual cages for 7 days given the standard 
feed and water. The room temperature ranged 
25–280C with 12 hours light cycle (6:00 a.m. to 
6:00 p.m.). Rat’s cages was cleaned every day. 
Blood sampling was conducted through plexus 
retroorbitalis to standardize blood glucose before 
it was conditioned with type-2 diabetes mellitus. 
Twenty rats were conditioned T2DM with high-
fat feeding for 14 days (Sathyadevi et al. 2014) 
followed by NA induction with the dose of 
110 mg/kg body weight via the intraperitoneal 
injection and 15 minutes later were given the STZ 
intraperitoneal induction with a dose of 45 mg/kg 
body weight (Ghasemi et al. 2014). Before the 
STZ induction, rats were fasted for 8–10 hours. 
After 3 days of STZ induction, rats were fasted 
for 8–10 hours (Gheibi et al. 2017) and 2 ml blood 
drawn through the plexus retroorbitalis for blood 
glucose and insulin levels analysis. Rats full filed 
the T2DM criteria if the fasting serum glucose 
levels was ≥200 mg/dl (Gheibi et al. 2017).
Treatments of golden berry juice and 
quercetin. Rats were divided into 5 groups: 
healthy group without treatments (K-), T2DM 
positive control group without treatments (K+), 
T2DM group with treatment of 1 ml/200 g 
BW/day of GB juice (X1), T2DM group with 
treatment of 5 ml/200 g BW/day of GB juice 
(X2), and T2DM group with treatment of 6 
mg/200 g BW/day of quercetin (X3). The dose 
of 1 ml/200 g BW/day of GB juice was based 
on Hassan & Ghoneim (2013) who stated that 
the dose could lower blood glucose in diabetic 
rats significantly, while the 5 ml/200 g BW/day 
dose of GB juice was based on ±1 glass of fruit 
juice consumed by humans. Quercetin was used 
as standard therapy in experimental animals with 
T2DM. The 6 mg/200 g BW/day dose of GB juice 
was the effective dose to lower blood glucose 
significantly compared to T2DM control group 
based on previous study of Chis et al. (2015). 
Quercetin was homogenized with a 0.5% 
Sodium-Carboxymethil cellulose (NA-CMC) 
each into 5 ml of volume. The making of GB 
juices and quercetin solution were prepared 
every day in the morning then immediately 
administered to T2DM rats via a gastric tube once 
a day. The GB juice and quercetin in T2DM rats 
were administered for 28 days. Blood sampling 
was conducted at the end of the study through 
plexus retroorbitalis for analysis of blood glucose 
and insulin levels. Insulin resistance level was 
indicated by the value of Homeostasis Model 
Assessment Insulin Resistance (HOMA-IR) 
with the formula as follow; HOMA-IR = (blood 
glucose level (mg/dl) x insulin level (μU/ml) 
divided by 405  (Esteghamati A et al. 2010). 
The study methods had received approval from 
the Ethics Committee for Health Research in 
Diponegoro University and Dr. Kariadi Hospital, 
register number 89/EC/H/FK-RSDK/XII/2017.
Data analysis
Data normality was tested by Shapiro-Wilk 
test. All of the data had normal distributions, thus 
the testing for the differences between before and 
after treatments used the paired t-test. Analysis of 
the effects of the differences between groups used 
the One-Way ANOVA test followed Tamhane 
post hoc (p<0.05) for blood gluce and  HOMA-
IR analysis, while for insulin analysis it was 
followed by Bonferroni post hoc test (p<0.05).
RESULTS AND DISCUSSION
The quercetin content in GB juices and 
fruit form have been reported previously (Puente 
et al. 2011). The quercetin’s content of GB juice 
in this study was 20.775 µg/ml of juice. 
Conditioning of type-2 diabetes 
mellitus. Prior to the treatment of GB juice and 
quercetin, blood glucose level was tested as a 
standard category of healthy rats and showed 
the homogeneous level of blood glucose level 
in the samples (Table 1). Conditioning of type-
2 diabetes mellitus in this study was conducted 
by high-fat feeding for 14 days and induction of 
STZ. Blood glucose levels of all rats were more 
than 200 mg/dl after conditioning of T2DM 
(Table 2). 
High-fat feeding aimed to establish 
condition of insulin resistance. It led to reduction 
in the activation of phosphatidylinositol 
3-kinase (PI3K)/Akt, which affected tyrosine 
phosphorylation and decreased IRS so it could 
reduce insulin signaling (Gheibi et al. 2017). 
The STZ inducted later causes a breakdown 
of deoxyribonucleic acid strand (DNA) and 
overexpression activation of poly synthase (ADP-
ribose) which was an enzyme to repair DNA. The 
rats was induced with NA at 15 minutes prior the 
STZ, it aimed to provide protection for pancreatic 
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β-cells from toxic effects of excessive STZ and 
created type-2 diabetes mellitus in rats (Zuloaga 
et al. 2014)
The administration of golden berry 
juice on levels of blood glucose, insulin, and 
HOMA-IR. Paired t-test showed that there were 
a decrease in blood glucose level (Table 2), an 
increase in insulin level (Table 3), and a decrease 
in HOMA-IR value (Table 4) with treatment of 
GB juice with a 1 ml/200 g BW/day dose and 
5 ml/200 g BW/day dose significantly in the 
before and after treatments (p<0.05). There 
were significant differences in changes of mean 
value with  GB juice X1 and X2 treatments 
compared to the K(+) in lowering blood glucose 
level, increasing insulin level, and decreasing 
HOMA-IR (p<0.05). This findings were in line 
with Hassan & Ghoneim (2013) who stated that 
administration of GB juice 1 ml/day could lower 
blood glucose significantly compared to diabetic 
control group and blood glucose level in group 
with The GB juice treatment was comparable 
to healthy rats group. Further, Sathyadevi et 
al. (2014) also found that GB extract could 
lower blood glucose and increase insulin levels 
significantly compared to diabetic control group.
The decreased values of blood glucose 
level in treatments of GB juice 1 ml/200 g BW/
day and 5 ml/200 g BW/day were equal to 
quercetin at dose of 6 mg/200 g BW/day. It was 
no significant differences between treatments in 
X1, X2, and X3 in the Tamhane post hoc test 
(p>0.05) (Table 3). The largest decrease in blood 
glucose level was shown by the GB juice tearment 
of 5 ml/200 g BW/day with the value of 110.44 
± 10.63. It was most likely influenced by the rich 
antioxidants contents of GB juice in addition to 
its quercetin content. Previous study found that 
GB juice contains several phenolic substance, 
including quercetin as major phenolic content and 
followed by myrecetin and kaempferol (Puente et 
al. 2011) which could play a role in decreasing 
blood glucose level.
As anti-diabetic agents, quercetin, 
myrecetin, and kaempferol available at various 
tissues, such as in the muscle. Quercetin for 
example, promotes glucose uptake in the skeletal 
muscle tissue by increasing the glucose transporter 
4 (GLUT4) translocation. In the liver, these agents 
improve the glucokinase activity to increase 
glucose storage in the liver through activation of 
AMP-activated protein kinase (AMPK). AMPK is 
Table 1. The initial glucose level standardization
Treatment groups Initial glucose levels p 
K(-) 73.94±15.76
K(+) 69.26±5.77
X1 87.46±9.06 0.319
X2 73.27±5.93
X3 69.26±10.59
p; One-Way ANOVA test. K(-): healthy group + without 
treatments, K(+): T2DM + without treatments; X1: T2DM 
group + GB Juice 1 ml/200 g BW/day (X1); X2: T2DM 
group + GB Juice 5 ml/200 g BW/day; X3: T2DM group + 
Quercetin 6 mg/200 g BW/day; n: 25 samples
Table 2. Blood glucose levels before and after treatments of golden berry juices and quercetin
Treatment groups
Blood glucose level (mg/dl)
Δ p' p
Before After
K(-) 82.76±6.17 100.93±4.50 18.17±6.16a 0.003*
K(+) 212.93±9.42 282.30±20.75 69.37±25.31a 0.004*
X1 221.02±9.97 141.87±6.05 -79.15±12.56ab 0.000 0.000*
X2 224.16±11.91 113.72±4.43 -110.44±10.63ab 0.000*
X3 214.05±14.04 105.85±2.51 -108.20±14.12a 0.000*
p': Paired t-test; p: One-Way ANOVA test; a p<0.05 Tamhane post hoc test with K(+); b p<0.05 Tamhane post hoc test with 
X1; no significant differences in X2 and X3; K(-): healthy group + without treatments; K(+): T2DM + without treatments; X1: 
T2DM group + GB Juice 1 ml/200 g BW/day (X1); X2: T2DM group + GB Juice 5 ml/200 g BW/day; X3: T2DM group + 
Quercetin 6 mg/200 g BW/day; n: 25 samples
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an enzyme that regulates the homeostatic energy 
in the body through several mechanisms such 
as inhibiting the gluconeogenesis, increases the 
fatty acid oxidation, and increases the expression 
of GLUT4. In the gut, these agents help to 
decrease maltase activity and glucose transporter 
2 (GLUT2) that can reduce the absorption of 
glucose in the gut (Anjani et al. 2018; Alkhalidy 
et al. 2015).
The decreased insulin levels indicated 
a functional disorder of pancreatic β-cells and 
a reduction in pancreatic islet cells because 
conditioning of type-2 diabetes mellitus by 
high-fat feeding and induction of STZ. Antony 
et al. (2017) stated that histopathology test of 
pancreatic tissue in animal fed by high-fat and 
STZ induction showed reduction in pancreatic 
islet cells. This condition could form amyloid 
which triggered the ROS. The changes in insulin 
levels were significantly different between X1, 
X2, and X3 in Bonferroni post hoc test (p<0.05) 
(Table 4). The highest elevated levels of insulin 
could be seen in treatment of GB juice of 5 ml/200 
g BW/day with a mean value of 1.99±0.30. It 
was thought because of other active substances 
contents in addition to quercetin that help protect 
pancreatic β-cell and worked as an antioxidant 
agents. Puente et al. (2011) stated that GB juice 
contained vitamin C, vitamin E, quercetin, 
myericetin, and kaempferol. Those contents 
Table 3. Mean values of insulin level before and after treatments of GB juices and quercetin
Treatment groups
Blood glucose level (mg/dl)
Δ p' p
Before After
K(-) 16.49±0.19 15.65±0.22 -1.09±0.39abc 0.003*
K(+) 12.72±0.16 11.82±0.14 -0.90±0.19bc 0.000*
X1 12.76±0.12 13.02±0.14 0.26±0.11ac 0.007* 0.000*
X2 12.74±0.26 14.53±0.17 1.99±0.30ab 0.000*
X3 12.69±0.23 14.12±0.18 1.42±0.35abc 0.001*
p': Paired t test; p: One-Way ANOVA test; a p<0.05 Bonferroni post hoc test with K(+); b p<0.05 Bonferroni post hoc test with 
X1; c p<0.05 Bonferroni post hoc test with X2; K(-): healthy group + without treatments; K(+): T2DM + without treatments; 
X1: T2DM group + GB Juice 1 ml/200 g BW/day (X1); X2: T2DM group + GB Juice 5 ml/200 g BW/day; X3: T2DM group 
+ Quercetin 6 mg/200 g BW/day; n: 25 samples
Table 4. Mean values of HOMA-IR before and after treatments of GB juices and quercetin
Treatment groups
Blood glucose level (mg/dl)
Δ p' p
Before After
K(-) 3.42±0.28 3.89±0.13 0.48±0.22 0.028*
K(+) 6.69±0.29 8.24±0.61 1.55±0.82 0.027*
X1 6.96±0.33 4.56±0.17 -2.40±0.39a 0.000* 0.000*
X2 7.06±0.40 4.14±0.19 -2.92±0.29a 0.000*
X3 6.71±0.34 3.68±0.09 -3.02±0.37a 0.000*
p': Paired t test; p: One-Way ANOVA test; a p<0.05 Tamhane post hoc test with K(+); K(-): healthy group without treatments; 
K(+): T2DM + without treatments; X1: T2DM group + GB Juice 1 ml/200 g BW/day (X1); X2: T2DM group + GB Juice 5 
mL/200 g BW/day; X3: T2DM group + Quercetin 6 mg/200 g BW/day; n: 25 samples  
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can help quercetin in GB juice in providing 
more protection to β-cells as antioxidant agents. 
(Garcia-Bailo et al. 2011; Al-Numair et al. 2015) 
compared to quercetin alone.
GB juice with a dose of 1 ml/200 g BW/
day and 5 ml/200 g BW/day had same effect with 
a 6 mg/200 g BW/day of quercetin treatment 
in improving insulin resistance as shown in 
Tamhane post hoc test with p>0.05 at X1, X2 and 
X3 treatments (Table 4).  Previous study found 
that phenolic compounds and antioxidant activity 
in GB juice was high. Phenolic compound in GB 
juice provides a great potential for prevention or 
management of chronic disease. 
Our findings supports the Choi et al. 
(2015) findings which stated that administration 
of quercetin for 10 weeks to rats induced by STZ 
could lower HOMA-IR significantly compared 
to diabetic control group (Choi et al. 2015). 
Quercetin is a powerful antioxidant that can 
capture free radicals and bind transition metal 
ions. Quercetin is also one of the best ROS 
(O2- and ONOO-) catcher. Anti-inflammatory 
effect of quercetin was able to reduce levels of 
pro-inflammatory cytokines like tumor necrosis 
factor alpha (TNF-α) by inhibiting the expression 
of Nuclear Factor Kappa Beta (NF-Kβ) (Choi 
et al. 2015; Luo et al. 2015). The inhibition of 
NF-Kβ expression could reduce insulin receptor 
substrate (IRS)-1 serine phosphorylation and 
increase expression of IRS-1 (Luo et al. 2015). 
IRS-1 protein was an important protein in 
improving insulin sensitivity.
CONCLUSION
We found evidences that GB juice was 
able to lower blood glucose level, increase 
insulin level, and improve insulin resistance. The 
effect of GB juice with a dose of 1 ml and 5 ml 
is comparable to quercetin with an adimistration 
dose of 6 mg/200 g BW/day in improving the 
blood glucose and HOMA-IR. In addition, the GB 
juice was better than quercetin in improving the 
insuline level. This corroborated the findings that 
GB juice is a potential nutrition support for type-
2 diabetes mellitus. Further research is necessary 
to test the complete phytochemical contents of 
GB juice and to analyze its effect on other anti-
inflammatory and antioxidant parameters in 
T2DM to deepen our understanding on the role 
and mechanisms of GB juice in T2DM.
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